Skip to main content
Sign In

Paula D. Riggs, MD


Contact Info:

Building 500, Rm. E4303
Phone:  303-724-2235
EmailDr. Riggs

Clinical/Research Interests:
Dr. Riggs is interested in the development and testing of evidence-based integrated treatment for SUD, psychiatric comorbidity, behavioral and psychosoical problems in adolescents - Integrated Treatment for Teens (ITT).


University of Colorado-Denver  BA  1976

University of Colorado-Denver  MA  1979

University of Colorado School of Medicine  MD  1989

Co-Chair, Adolescent Substance Abuse Committee, AACAP,1997-2001         

NIDA Treatment Research Study Section (NIDA-E), 1998-2009

Co-Chair, Committee on Adolescent Substance Abuse, American Association of Addiction Psychiatry (AAAP), 2001-2003          

Co-Chair, Portfolio Coordinating Committee, Clinical Trials Network, NIDA, 2002-2004         

Editorial Board, Journal of American Academy of Child & Adolescent Psychiatry (JAACAP), 2003-2008         

Scientific Advisory Board, Economic Evaluation Methods: Development and Applications. Grant No. R01 DA018645, Michael French, PI, 2005-2009         

Appointment to Alcohol and Substance Use Guideline Committee Meeting; Colorado Clinical Guidelines Collaborative, Colorado Department of Public Health and Environment, 2007-2008         

Editorial Board, JAACAPEditor of JAACAP Pediatric Addiction Review Series, 2006-  

Riggs, P. D., Baker, S., Mikulich, S. K., Young, S., Crowley, T. J. (1995). Depression in substance dependent delinquents. Journal of the American Academy of Child and Adolescent Psychiatry, 34(6), 764-771.

Riggs, P. D., Thompson, L. L., Mikulich, S. K., Whitmore, E. A., Crowley, T. J. (1996). An Open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry35(8), 1018-1024.

Riggs, P. D., Mikulich, S. K., Coffman, L., Crowley, T..J. (1997). Fluoxetine in drug-dependent delinquents: An Open Trial. Journal of Child and Adolescent Psychopharmacology7(2), 87-95.

Riggs, P. D., Mikulich, S. K., Whitmore, E. A., Crowley, T. J. (1999). Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug and Alcohol Dependence54, 195-205.

Riggs, P. D., Davies, R. D. (2002). A Clinical Approach to Integrating Treatment for Adolescent Depression and Substance Abuse. Journal of the American Academy of Child and Adolescent Psychiatry41(10), 1253-1255.

Riggs, P. D., Hall, S. K., Mikulich-Gilbertson, S. K., Lohman, M., Kayser, A. (2004). A randomized controlled trial of pemoline for attention deficit hyperactivity disorder in substance abusing adolescents. Journal of the American Academy of Child and Adolescent Psychiatry43(4), 420-429.

Thurstone, C., Riggs, P. D., Klein, C., Mikulich-Gilbertson, S. K. (2007). A one-session human immunodeficiency virus risk-reduction intervention in adolescents with psychiatric and substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry16, 306-311.

Riggs, P. D., Mikulich-Gilbertson, S. K., Davies, R. D., Lohman, M., Klein, C., Stover, S. K. (2007). A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Archives of Pediatric and Adolescent Medicine161(11), 1-9.

Riggs, P. D., Thompson, L. L., Tapert, S. F., Frascella, J., Mikulich-Gilbertson, S., Dalwani, M., Laudenslager, M., Lohman, M. (2007). Advances in neurobiological research related to interventions in adolescents with substance use disorders: Research to practice. Drug and Alcohol Dependence91(2-3), 306-311.

Riggs, P. D., Levin, F., Green, A. I., Vocci, F. (2008). Co-morbid psychiatric and substance abuse disorders: Recent treatment research. Substance Abuse29(3), 51-63.​

8/15/08 - 6/30/13,  NIH/NIDA R01 DA022284 (Riggs),  Bupropion for ADHD in Adolescents with Substance Use Disorders


9/30/06 - 5/31/10, NIH/NIDA R25 DA020472 (Roget),    NIDA Enters College: Infusing the Science of Addiction into University Curricula

Role: Senior Scientific Consultant, Co-Investigator


9/01/05 - 8/31/09,  NIH/NIDA U10 DA013732 (Somoza)  Clinical Trials Network, Ohio Valley Node

Role: Lead Investigator, CTN multisite trial“A Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder in Adolescents with Substance Use Disorders” (CTN-0028)


5/1/06 - 4/30/09, NIH/NIDA R01 DA018679 (Davies), Martial Arts as Early Intervention for Teen Drug Abuse   

Role: Senior Scientific Consultant, Co-Investigator


10/01/04 - 08/31/0, NIH/NIDA9 K12 DA00035 (Riggs), AACAP Physician Scientist Program in Substance Abuse